ARTICLE | Clinical News
FibroGen preclinical data
May 22, 2000 7:00 AM UTC
FibroGen said that its rhCIII induced human platelets to completely aggregate at a lower concentration than bovine collagen I, and that rhCIII had a 60 percent reduction in bleeding time compared to c...